buying levels for Maruti are in the range of 3800-3000 because I'm comparing the ongoing correction with 2008 crisis..that time it corrected almost 70% so starting from peak of 10000, this much correction is warranted. this whole theory will be proven wrong if there's GST cut in auto sector or demand improves exponentially and this probability is minuscule.
Its all set for its downward journey. 380-340-280 are the levels with strong support. one should be a buyer around 280. no longs before that. lets see how the business gets hit by COVID19 in this quarter.
7600 will be nice levels to buy. subsequent downside levels are also marked. buy staggered.
looking at the intensity of sell off today, I'll deploy cash in nifty ETF at around 10800 then 10400 and last 10000. after that I'll wait for trend reversal. but do continue your SIP and buy quality stocks. if not buying then atleast don't sell your holdings in loss.. sooner or later markets will resume uptrend.
it has been oscillating in between 700-760 from last six months. one should sell on the higher side with strict SL and buy on the lower side of the range for positional trades. and for investment add around 710 and 640. one can also buy aggressively if it crosses the higher end convincingly.
all set to break new lows after showing closing below 420. word of caution here, no signs of bottoming out
attractive at CMP. insurance and related sector is to be In for this decade.
utilise this unfilled gap for portfolio. sooner or later CV industry will revive and biggest NBFC beneficiary will be SRTRANSFIN
there's been a massive sell off taking the toll on the downside to 17% from all time high. either one can wait for trend reversal or start buying small quantities for long term. it could underperform or remain sideways or quite some time. but its worth taking a risk and start buying.
it will be an excellent buy in the range of 8400-7400. till the accusation by Hindustan uniliver is not complete, I think it should oscillate in this range and ultimately your shares will be converted to Hindustan uniliver. it will interesting to see how gsk consumer utilises the cash on its books before the accusation, a hefty dividend or something else.